Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS/autophagy

Toxicology Letters

Volumn 232, Issue 2, 2015, Pages 349-355

  Liu, Huailei ^a,b   Zhang, Weiguang ^a,b   Wang, Kaikai ^a,b   Wang, Xiaoxiong ^a,b   Yin, Fei ^a,b   Li, Chenguang ^a,b   Wang, Chunlei ^a,b   Zhao, Boxian ^a,b   Zhong, Chen ^a,b   Zhang, Jiakang ^a,b   Peng, Fei ^a,b   Bi, Yunke ^a,b   Shen, Chen ^a,b   Hou, Xu ^a,b   Zhang, Daming ^a,b   Liu, Yaohua ^a,b   Ai, Jing ^b   Zhao, Shiguang ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Autophagy; Cystine cysteine; Glioma; Methionine; ROS

Indexed keywords

CYSTINE; GLUTATHIONE; METHIONINE; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOPHAGY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIET; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; METABOLISM; STRESS; ANIMAL; BAGG ALBINO MOUSE; BRAIN TUMOR; DEFICIENCY; DRUG EFFECTS; GLIOMA; MOUSE; NUDE MOUSE; PATHOLOGY;

ANIMALS; AUTOPHAGY; BRAIN NEOPLASMS; CELL PROLIFERATION; CYSTINE; GLIOMA; METHIONINE; MICE; MICE, INBRED BALB C; MICE, NUDE; REACTIVE OXYGEN SPECIES;

EID: 84919782852     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.11.011     Document Type: Article

References (36)

1. Ai J., Sun L.H., Che H., Zhang R., Zhang T.Z., Wu W.C., Su X.L., Chen X., Yang G., Li K., Wang N., Ban T., Bao Y.N., Guo F., Niu H.F., Zhu Y.L., Zhu X.Y., Zhao S.G., Yang B.F. MicroRNA-195 protects against dementia induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. J. Neurosci. 2013, 33:3989-4001.
2. Bellot G.L., Liu D., Pervaiz S. ROS, autophagy, mitochondria and cancer: ras the hidden master?. Mitochondrion 2013, 13:155-162.
3. Cavuoto P., Fenech M.F. A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension. Cancer Treat. Rev. 2012, 38:726-736.
4. Dai L., Cao Y., Chen Y., Parsons C., Qin Z. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J. Hematol. Oncol. 2014, 7:30.
5. Fotakis G., Timbrell J.A. Sulfur amino acid deprivation in cadmium chloride toxicity in hepatoma cells. Environ. Toxicol. Pharmacol. 2006, 22:334-337.
6. Fu J., Shao C.J., Chen F.R., Ng H.K., Chen Z.P. Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines. Neuro. Oncol. 2010, 12:328-340.
7. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
8. Ishimoto T., Nagano O., Yae T., Tamada M., Motohara T., Oshima H., Oshima M., Ikeda T., Asaba R., Yagi H., Masuko T., Shimizu T., Ishikawa T., Kai K., Takahashi E., Imamura Y., Baba Y., Ohmura M., Suematsu M., Baba H., Saya H. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011, 19:387-400.
9. Jayakumar S., Kunwar A., Sandur S.K., Pandey B.N., Chaubey R.C. Differential response of DU145 and PC3 prostate cancer cells to ionizing radiation: role of reactive oxygen species, GSH and Nrf2 in radiosensitivity. Biochim. Biophys. Acta 2014, 1840:485-494.
10. Jiang Y.S., Wang F.R. Caloric restriction reduces edema and prolongs survival in a mouse glioma model. J. Neurooncol. 2013, 114:25-32.
11. Kaza N., Kohli L., Roth K.A. Autophagy in brain tumors: a new target for therapeutic intervention. Brain Pathol. 2012, 22:89-98.
12. Levine B., Kroeme G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
13. Levine B., Yuan J. Autophagy in cell death: an innocent convict. J. Clin. Invest. 2005, 115:2679-2688.
14. Li L., Ishdorj G., Gibson S.B. Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment. Free Radic. Biol. Med. 2012, 53:1399-1410.
15. Lo M., Ling V., Wang Y.Z., Gout P.W. The xc-cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance. Br. J. Cancer 2008, 99:464-472.
16. Martinet W., Agostinis P., Vanhoecke B., Dewaele M., De Meyer G.R. Autophagy in disease: a double-edged sword with therapeutic potential. Clin. Sci. (Lond) 2009, 116:697-712.
17. Modis K., Coletta C., Asimakopoulou A., Szczesny B., Chao C., Papapetropoulos A., Hellmich M.R., Szabo C. Effect of S-adenosyl-l-methionine (SAM), an allosteric activator of cystathionine-beta-synthase (CBS) on colorectal cancer cell proliferation and bioenergetics in vitro. Nitric Oxide. 2014, 41:146-156.
18. Najim N., Podmore I.D., McGown A., Estlin E.J. Methionine restriction reduces the chemosensitivity of central nervous system tumour cell lines. Anticancer Res. 2009, 29:3103-3108.
19. Nogueira V., Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 2013, 19:4309-4314.
20. Ogier G., Chantepie J., Deshayes C., Chantegrel B., Charlot C., Doutheau A., Quash G. Contribution of 4-methylthio-2-oxobutanoate and its transaminase to the growth of methionine-dependent cells in culture. Effect of transaminase inhibitors. Biochem. Pharmacol. 1993, 45:1631-1644.
21. Park E.J., Choi K.S., Kwon T.K. β-Lapachone-induced reactive oxygen species (ROS) generation mediates autophagic cell death in glioma U87 MG cells. Chem. Biol. Interact. 2011, 189:37-44.
22. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 2012, 24:981-990.
23. Reis M., Czupalla C.J., Ziegler N., Devraj K., Zinke J., Seidel S., Heck R., Thom S., Macas J., Bockamp E., Fruttiger M., Taketo M.M., Dimmeler S., Plate K.H., Liebner S. Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J. Exp. Med. 2012, 209:1611-1627.
24. Sato A., Okada M., Shibuya K., Watanabe E., Seino S., Narita Y., Shibui S., Kayama T., Kitanaka C. Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells. Stem Cell Res. 2014, 12:119-131.
25. Scheck A.C., Abdelwahab M.G., Fenton K.E., Stafford P. The ketogenic diet for the treatment of glioma: insights from genetic profiling. Epilepsy Res. 2012, 100:327-337.
26. Seglen P.O., Gordon P.B. 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 1982, 79:1889-1892.
27. Shen S., Zhang Y., Zhang R., Tu X., Gong X. Ursolic acid induces autophagy in U87MG cells via ROS-dependent endoplasmic reticulum stress. Chem. Biol. Interact. 2014, 218:28-41.
28. Shi J., Zuo H., Ni L., Xia L., Zhao L., Gong M., Nie D., Gong P., Cui D., Shi W., Chen J. An IDH1 mutation inhibits growth of glioma cells via GSH depletion and ROS generation. Neurol. Sci. 2014, 35:839-845.
29. Shiraki N., Shiraki Y., Tsuyama T., Obata F., Miura M., Nagae G., Aburatani H., Kume K., Endo F., Kume S. Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. Cell Metab. 2014, 19:780-794.
30. Vene R., Castellani P., Delfino L., Lucibello M., Ciriolo M.R., Rubartelli A. The cystine/cysteine cycle and GSH are independent and crucial antioxidant systems in malignant melanoma cells and represent druggable targets. Antioxid. Redox Signal. 2011, 15:2439-2453.
31. Wang X., Guo X., Yu W., Li C., Gui Y., Cai Z. Expression of methionine adenosyltransferase 2A in renal cell carcinomas and potential mechanism for kidney carcinogenesis. BMC Cancer 2014, 14:196.
32. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
33. Wolf A., Agnihotri S., Micallef J., Mukherjee J., Sabha N., Cairns R., Hawkins C., Guha A. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J. Exp. Med. 2011, 208:313-326.
34. Yan H., Parsons D.W., Jin G., McLendon R., Rasheed B.A., Yuan W., Kos I., Batinic-Haberle I., Jones S., Riggins G.J., Friedman H., Friedman A., Reardon D., Herndon J., Kinzler K.W., Velculescu V.E., Vogelstein B., Bigner D.D. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 2009, 360:765-773.
35. You B.R., Park W.H. Zebularine-induced apoptosis in Calu-6 lung cancer cells is influenced by ROS and GSH level changes. Tumour Biol. 2013, 34:1145-1153.
36. Zuccoli G., Marcello N., Pisanello A., Servadei F., Vaccaro S., Mukherjee P., Seyfried T.N. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr. Metab. (Lond) 2013, 7:33.